Navigation Links
Bud Owen and Tony Click Join Clinverse, Inc. as Chief Financial Officer and Chief Technology Officer
Date:7/31/2013

Raleigh, NC (PRWEB) July 31, 2013

Clinverse, Inc., a global technology and eclinical commerce network for clinical trials, announced today the addition of Bud Owen as Chief Financial Officer and Tony Click as Chief Technology Officer. Both Bud and Tony bring extensive experience in their respective fields and serve as strategic members of the management team for the company.

In his role as CFO, Bud leads all financial aspects of the company, including accounting, treasury, tax and human resources activities. He is a veteran senior finance executive who was most recently with Clinipace, Inc., a global CRO. Prior to Clinipace, Bud served as CFO at a number of global companies in the software, web services, media and chemical industries. During his career, he has been either a principal or an advisor in more than 40 M&A transactions with a total transaction value of $1.5 billion. Bud has a Master of Business Administration from Queens University (Canada) and is an Ernst & Young (Toronto) alumni.

As Chief Technology Officer, Tony is responsible for all technical and architectural aspects of Clinverse’s software and eclinical commerce network. He brings more than 20 years of experience developing customer software solutions across many industries including finance, insurance, publishing, telecom, construction and utilities. His specialties include systems with high throughput, computationally intensive and ‘Big Data’ requirements. Prior to joining Clinverse, Tony provided outsourced CTO services for early-stage startups and served as the VP of Enterprise Architecture at Merkle, a database analytics company. Tony also ran his own consulting firm for 11 years, which delivered architectural and project management services. He received a Bachelor of Science in Electrical Engineering from Virginia Tech and a Master of Business Administration from Duke University’s Fuqua School of Business.

"We look forward to leveraging Bud and Tony’s industry knowledge and expertise to continue to grow our lead in the area of financial lifecycle systems for the clinical trials industry," said Steve Ayala, Clinverse co-founder and president. "Their leadership and experience are critical to our success as we continue to expand globally and seek to provide our customers with exceptional financial process automation solutions that fill an important, yet unmet need in clinical trials."

About Clinverse, Inc.

Clinverse, Inc. is a global technology and financial services company that delivers highly secure, cloud-based financial management and payment solutions for the clinical trials industry. Founded in 2008 and headquartered in Raleigh, NC, the company delivers clinical financial solutions through the only truly collaborative and transparent financial management and payment platform. Used by leading BioPharma companies, Clinverse has developed ClinPay®, a fully-configurable, game-changing SaaS-based platform which manages tens of millions of dollars in financial transactions for thousands of global sites while supporting payments in 140 different currencies. For more information, please visit http://www.clinverse.com.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10973719.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC
2. Clinverse, Inc. Introduces ClinSpend to Meet Challenges of Sunshine Act Reporting Requirements
3. Clinverse, Inc. Exhibiting and Showcasing Its Technology at DIA 2013
4. Arecor Appoints Dr. Sarah Howell as Chief Operating Officer
5. John Saltamartine to Lead Operations as VR Laboratories Chief Operating Officer
6. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
7. Rhythm Names Lex Van der Ploeg Chief Scientific Officer
8. Biocartis Names Dr. Nayan Gregory Parekh As Chief Executive Officer
9. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
10. AFFiRiS AG Invests Into Human Capital - Chief Business Officer Recruited
11. Codexis Names Wes Bolsen VP and Chief Marketing Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... WuXi Biologics, a leading open-access R&D ... and a WuXi AppTec Affiliate, today announced that ... Excellence Award from IMAPAC, a leading consulting firm. ... recognize outstanding leaders and trend-setters of today, and ... biomanufacturing experts in the industry, along with the ...
(Date:3/29/2017)... , March 29, 2017  Halozyme Therapeutics, ... oncology and drug-delivery therapies, today announced that an ... and Drug Administration voted 11 to 0 that ... skin) injection was favorable for patients in the ... lymphoma and chronic lymphocytic leukemia. The FDA action ...
(Date:3/29/2017)... Research and Markets has announced the addition ... Industry Forecast to 2025" report to their offering. ... The Global Agricultural Chelates ... over the next decade to reach approximately $825.4 million by 2025. ... forecasts for all the given segments on global as well as ...
(Date:3/29/2017)... , March 29, 2017 The Global Microfluidic ... report is a specialized and comprehensive study on the existing state ... America , Europe and ... Middle East and Africa . ... Browse 172 Tables and ...
Breaking Biology Technology:
(Date:3/16/2017)... CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made in ... ... combined in one project, multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog Identification ... Used combined in one project, multi-biometric solutions provide a ... ...
(Date:3/7/2017)... Brandwatch , the leading social intelligence company, today ... to uncover insights to support its reporting, help direct future ... UK,s leading youth charity will be using Brandwatch Analytics social listening ... better understanding of the topics and issues that are a priority ... ...
(Date:3/2/2017)... 2, 2017 Summary This report ... Merck KGaA and its partnering interests and activities since ... Description The Partnering Deals and Alliance since 2010 ... of one of the world,s leading life sciences companies. ... purchase to ensure inclusion of the most up to ...
Breaking Biology News(10 mins):